Align Technology (ALGN) FY2025 results: revenue $4.0 billion, up 0.9% on the year
Align Technology Inc. (ALGN) reported revenue of $4.0 billion for fiscal 2025, the year ended 31 December 2025, up 0.9% on the year before. Net income was $410 million, down 2.6%, and diluted earnings per share $5.65. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 6 new.
- Q4 revenue rose 5.3% year-over-year: Q4 total revenues were $1,047.6 million, up 5.2% sequentially and 5.3% year-over-year. Foreign exchange added about $14.8 million year-over-year.
- Q4 results came in above expectations: Management said Q4 revenues, Clear Aligner volumes, and non-GAAP gross and operating margins came in above its own expectations.
- Q4 Clear Aligner volume up 7.7%: Q4 Clear Aligner volume was 676.9 thousand cases, up 4.5% sequentially and 7.7% year-over-year. Clear Aligner revenue was $838.1 million, up 5.5%.
- Q4 restructuring and depreciation charges $67.5M: Management said Q4 restructuring and accelerated depreciation charges totaled $67.5 million, excluded from non-GAAP results.
- Q4 GAAP operating margin 14.8%: Q4 GAAP operating margin was 14.8%, against 14.5% a year earlier; non-GAAP operating margin was 26.1%, against 23.2%.
From this 10-K
Align Technology is a global medical device company that designs, manufactures and markets Invisalign clear aligners for treating malocclusion, meaning misaligned teeth, along with Vivera retainers for retention, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and manufacturing software for dental laboratories and practitioners. It ties those together as the Align Digital Platform, a suite of proprietary technologies and services running from patient to doctor to lab. Corporate headquarters are in Tempe, Arizona, with regional headquarters in Raleigh, Rotkreuz in Switzerland and Singapore. There are two segments: Clear Aligner, approximately 80 percent of worldwide net revenues in 2025, and Imaging Systems and CAD/CAM Services, the remaining 20 percent. The company had approximately 20,290 employees at the end of 2025, about 3.1 percent fewer than a year earlier. The filing states that over the past 28 years Align has helped doctors treat over 22 million patients with the Invisalign System.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 4,035 | 3,999 | 3,862 | +0.9% | |
| Cost of revenue | 1,324 | 1,200 | 1,155 | +10.3% | |
| Gross profit | 2,711 | 2,799 | 2,707 | -3.1% | |
| Gross margin | 67.2% | 70.0% | 70.1% | ||
| Research and development | 370 | 364 | 347 | +1.6% | |
| Selling, general and administrative | 1,756 | 1,763 | 1,703 | -0.4% | |
| Operating income | 546 | 608 | 643 | -10.2% | |
| Operating margin | 13.5% | 15.2% | 16.7% | ||
| Pre-tax income | 585 | 609 | 641 | -3.9% | |
| Income tax | 175 | 188 | 196 | -6.7% | |
| Effective tax rate | 29.9% | 30.8% | 30.6% | ||
| Net income | 410 | 421 | 445 | -2.6% | |
| Net margin | 10.2% | 10.5% | 11.5% | ||
| Diluted EPS | $5.65 | $5.62 | $5.81 | +0.5% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 593 | 738 | 786 | -19.6% | |
| Capital expenditure | 102 | 116 | 178 | -11.4% | |
| Free cash flow | 491 | 623 | 608 | -21.2% | |
| Free cash flow margin | 12.2% | 15.6% | 15.7% | ||
| Cash from investing | -112 | -255 | -196 | ||
| Cash from financing | -465 | -356 | -598 | ||
| Depreciation and amortisation | 237 | 145 | 142 | +63.7% | |
| Share-based compensation | 186 | 174 | 154 | +7.0% | |
| Buybacks | 466 | 353 | 592 | +32.0% | |
| Diluted shares, weighted | 73m | 75m | 77m | -3.2% | |
| Shares outstanding at period end | 71m | 74m | 75m | -3.4% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 4,049 | 3,852 | 3,630 | +5.1% | |
| Debt | 0.0 | 0.0 | 0.0 | ||
| Operating lease liabilities | 82.5 | 88.2 | 97.0 | -6.5% | |
| Other liabilities | 2,102 | 2,274 | 2,356 | -7.6% | |
| Total liabilities and equity | 6,234 | 6,215 | 6,084 | +0.3% | |
| Fixed assets | 1,131 | 1,271 | 1,291 | -11.0% | |
| Goodwill | 492 | 443 | 420 | +11.1% | |
| Intangible assets | 93.9 | 103 | 82.1 | -9.2% | |
| Investments | n/a | 0.0 | 43.3 | ||
| Cash and equivalents | 1,095 | 1,044 | 937 | +4.9% | |
| Receivables | 1,102 | 996 | 903 | +10.7% | |
| Inventory | 226 | 254 | 297 | -11.0% | |
| Other assets | 2,093 | 2,103 | 2,110 | -0.5% | |
| Total assets | 6,234 | 6,215 | 6,084 | +0.3% |
10-K for the year ended 31 December 2025, filed 27 February 2026: the filing.